These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10434276)
1. A nomogram to evaluate intrinsic absorption rate constants of potential oral prolonged-release candidates. Dyar SC; Notari RE Pharm Dev Technol; 1999 Aug; 4(3):305-12. PubMed ID: 10434276 [TBL] [Abstract][Full Text] [Related]
2. Controlling drug effects through improved oral formulations. The pharmacokinetics of the prazosin gastrointestinal therapeutic system. DiPiro JT Am J Med; 1989 Aug; 87(2A):31S-35S. PubMed ID: 2764016 [TBL] [Abstract][Full Text] [Related]
3. Oral Drug Delivery Systems Applied to Launched Products: Value for the Patients and Industrial Considerations. Yoshida T; Kojima H Mol Pharm; 2023 Nov; 20(11):5312-5331. PubMed ID: 37856863 [TBL] [Abstract][Full Text] [Related]
4. A computational model for particle size influence on drug absorption during controlled-release colonic delivery. Waterman KC; Sutton SC J Control Release; 2003 Jan; 86(2-3):293-304. PubMed ID: 12526825 [TBL] [Abstract][Full Text] [Related]
5. Bio-mimetic drug delivery systems designed to help the senior population reconstruct melatonin plasma profiles similar to those of the healthy younger population. Li Y; Wang L; Wu L; Zhang X; Li X; Guo Z; Li H; York P; Gui S; Zhang J Acta Pharm Sin B; 2014 Feb; 4(1):60-6. PubMed ID: 26579365 [TBL] [Abstract][Full Text] [Related]
6. Physiological mechanism-based analysis of dose-dependent gastrointestinal absorption of L-carnitine in rats. Matsuda K; Yuasa H; Watanabe J Biopharm Drug Dispos; 1998 Oct; 19(7):465-72. PubMed ID: 9818713 [TBL] [Abstract][Full Text] [Related]
7. A modified residual method to estimate the zero-order absorption rate constant in a one-compartment model. Liu X; Brouwer KL; Pollack GM Biopharm Drug Dispos; 1997 Mar; 18(2):93-101. PubMed ID: 9099446 [TBL] [Abstract][Full Text] [Related]
8. Drug absorption: a practical method to estimate the absorption rate constant. Lambert C; du Souich P Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):217-29. PubMed ID: 7335952 [TBL] [Abstract][Full Text] [Related]
9. A method of determining the in vivo drug release rate constant of sustained-release preparation. Sun H; Chow MS Drug Metab Dispos; 1995 Apr; 23(4):449-54. PubMed ID: 7600910 [TBL] [Abstract][Full Text] [Related]
10. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation. Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538 [TBL] [Abstract][Full Text] [Related]
11. [Study on drug release in vitro and rat intestinal absorption of resveratrol nanoliposomes]. Wang XC; Hou SX; Li W; Li XY; Zhou YW Zhongguo Zhong Yao Za Zhi; 2007 Jun; 32(11):1084-8. PubMed ID: 17672350 [TBL] [Abstract][Full Text] [Related]
13. The relationship between drug input and mean residence time in the body. Bialer M; Look ZM; Silber BM; Yacobi A Biopharm Drug Dispos; 1986; 7(6):577-83. PubMed ID: 3828487 [TBL] [Abstract][Full Text] [Related]
14. Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption. Johnson KC Drug Dev Ind Pharm; 2003 Sep; 29(8):833-42. PubMed ID: 14570304 [TBL] [Abstract][Full Text] [Related]
15. In vivo evaluation of controlled-release products. Hwang SS; Bayne W; Theeuwes F J Pharm Sci; 1993 Nov; 82(11):1145-50. PubMed ID: 8289130 [TBL] [Abstract][Full Text] [Related]
16. DeMonS--a new deconvolution method for estimating drug absorbed at different time intervals and/or drug disposition model parameters using a monotonic cubic spline. Yu Z; Hwang SS; Gupta SK Biopharm Drug Dispos; 1997 Aug; 18(6):475-87. PubMed ID: 9267681 [TBL] [Abstract][Full Text] [Related]
17. The role of metabolites in bioequivalency assessment. III. Highly variable drugs with linear kinetics and first-pass effect. Jackson AJ Pharm Res; 2000 Nov; 17(11):1432-6. PubMed ID: 11205739 [TBL] [Abstract][Full Text] [Related]
18. Artesunate-clindamycin multi-kinetics and site-specific oral delivery system for antimalaric combination products. Strusi OL; Barata P; Traini D; Young PM; Mercuri S; Colombo G; Sonvico F; Bettini R; Colombo P J Control Release; 2010 Aug; 146(1):54-60. PubMed ID: 20457192 [TBL] [Abstract][Full Text] [Related]